UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association between prolonged metastatic free interval and recurrent metastatic breast cancer survival: findings from the SEER database

Breast cancer research and treatment, 2019-01, Vol.173 (1), p.209-216

2019

Volltextzugriff (PDF)

Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States

Breast cancer research and treatment, 2019-11, Vol.178 (2), p.419-426

2019

Volltextzugriff (PDF)

Cognitive Effects and Depression Associated With Taxane-Based Chemotherapy in Breast Cancer Survivors: A Meta-Analysis

Frontiers in oncology, 2021-04, Vol.11, p.642382

2021

Volltextzugriff (PDF)

Incorporating Tumor Characteristics to Maximize 21-Gene Assay Utility: A Cost-Effectiveness Analysis

Journal of the National Comprehensive Cancer Network, 2019-01, Vol.17 (1), p.39-46

2019

Volltextzugriff (PDF)

Adoption of Hypofractionated Whole-Breast Irradiation for Early-Stage Breast Cancer: A National Cancer Data Base Analysis

International journal of radiation oncology, biology, physics, 2014-12, Vol.90 (5), p.993-1000

2014

Volltextzugriff (PDF)

Patient preferences regarding incidental genomic findings discovered during tumor profiling

Cancer, 2016-05, Vol.122 (10), p.1588-1597

2016

Volltextzugriff (PDF)

Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study

PloS one, 2017-09, Vol.12 (9), p.e0184747-e0184747

2017

Volltextzugriff (PDF)

Utilization and outcomes of Eribulin Mesylate POst a cyclin-dependent kinase 4/6 inhibitor (CDK 4/6i): An observational real-World study in UnitEd States community oncology pRactices (EMPOWER)

Annals of oncology, 2019-05, Vol.30, p.iii54-iii54

2019

Volltextzugriff (PDF)

Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal

Journal of clinical oncology, 2018-06, Vol.36 (16), p.1619-1627

2018

Volltextzugriff (PDF)

Clinical benefit of treatment with eribulin mesylate for metastatic triple‐negative breast cancer: Long‐term outcomes of patients treated in the US community oncology setting

Cancer medicine (Malden, MA), 2018-09, Vol.7 (9), p.4371-4378

2018

Volltextzugriff (PDF)

Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States

Cancer, 2015-08, Vol.121 (15), p.2544-2552

2015

Volltextzugriff (PDF)

Adoption of Intensity Modulated Radiation Therapy For Early-Stage Breast Cancer From 2004 Through 2011

International journal of radiation oncology, biology, physics, 2015-02, Vol.91 (2), p.303-311

2015

Volltextzugriff (PDF)

Text Messaging to Increase Compliance with Adjuvant Endocrine Therapy in Breast Cancer

Cancer cell, 2020-09, Vol.38 (3), p.323-325

2020

Volltextzugriff (PDF)

Aging a Decade in a Day: Age Cutoff Bias in Adjuvant Therapy Allocation for Early-Stage Breast Cancer

International journal of radiation oncology, biology, physics, 2023-07, Vol.116 (4), p.747-756

2023

Volltextzugriff (PDF)

Self-Reported COVID-19 Infections and Social Mixing Behavior at Oncology Meetings

International journal of radiation oncology, biology, physics, 2022-09, Vol.114 (1), p.30-38

2022

Volltextzugriff (PDF)

Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ

Annals of surgical oncology, 2018-06, Vol.25 (6), p.1521-1529

2018

Volltextzugriff (PDF)

Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States

Advances in therapy, 2021-05, Vol.38 (5), p.2213-2225

2021

Volltextzugriff (PDF)

Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy

JAMA oncology, 2016-04, Vol.2 (4), p.508

2016

Volltextzugriff (PDF)

The impact of communication style on patient satisfaction

Breast cancer research and treatment, 2019-07, Vol.176 (2), p.349-356

2019

Volltextzugriff (PDF)

Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors

Journal of the National Comprehensive Cancer Network, 2018-05, Vol.16 (5), p.526-534

2018

Volltextzugriff (PDF)

Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States

Advances in therapy, 2021-06, Vol.38 (6), p.3487-3487

2021

Volltextzugriff (PDF)

Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States

Advances in therapy, 2021-05, Vol.38 (5), p.2226-2228

2021

Volltextzugriff (PDF)

Observational study of clinical outcomes of eribulin mesylate in metastatic breast cancer after cyclin-dependent kinase 4/6 inhibitor therapy

Future oncology (London, England), 2019-12, Vol.15 (34), p.3935-3944

2019

Volltextzugriff (PDF)

Novel Tool to Monitor Adherence to Oral Oncolytics: A Pilot Study

JCO clinical cancer informatics, 2021-06 (5), p.701-708

2021

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(95)

Publikationsform

Artikel
(111)
Tagungsberichte
(1)

Sprache

Englisch
(112)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Association between prolonged metastatic free interval and recurrent metastatic breast cancer survival: findings from the SEER database

Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States

Cognitive Effects and Depression Associated With Taxane-Based Chemotherapy in Breast Cancer Survivors: A Meta-Analysis

Incorporating Tumor Characteristics to Maximize 21-Gene Assay Utility: A Cost-Effectiveness Analysis

Adoption of Hypofractionated Whole-Breast Irradiation for Early-Stage Breast Cancer: A National Cancer Data Base Analysis

Patient preferences regarding incidental genomic findings discovered during tumor profiling

Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study

Utilization and outcomes of Eribulin Mesylate POst a cyclin-dependent kinase 4/6 inhibitor (CDK 4/6i): An observational real-World study in UnitEd States community oncology pRactices (EMPOWER)

Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal

Clinical benefit of treatment with eribulin mesylate for metastatic triple‐negative breast cancer: Long‐term outcomes of patients treated in the US community oncology setting

Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States

Adoption of Intensity Modulated Radiation Therapy For Early-Stage Breast Cancer From 2004 Through 2011

Text Messaging to Increase Compliance with Adjuvant Endocrine Therapy in Breast Cancer

Aging a Decade in a Day: Age Cutoff Bias in Adjuvant Therapy Allocation for Early-Stage Breast Cancer

Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study

Self-Reported COVID-19 Infections and Social Mixing Behavior at Oncology Meetings

Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ

Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States

Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy

The impact of communication style on patient satisfaction

Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors

Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States

Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States

Observational study of clinical outcomes of eribulin mesylate in metastatic breast cancer after cyclin-dependent kinase 4/6 inhibitor therapy

Novel Tool to Monitor Adherence to Oral Oncolytics: A Pilot Study

Suchergebnisse filtern